Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Pharmaceutical

Recent news which mentions Pharmaceutical

Gilead's Lenacapavir Plan Faces Global Hurdles As It Commits To No-Profit Access for 2 Million
Tickers GILD NEWS
Tags Pharmaceutical Top Stories Trading Ideas
From Benzinga
Analyst Views Mixed As Amgen's Weight Loss/Diabetes Drug MariTide Shows Promise But Has Dose Issues
Tickers AMGN NEWS
Tags Analyst Color Expert Ideas General
From Benzinga
Amgen (AMGN) Stock Falls After Mixed MariTide Trial Update
Tickers AMGN NEWS
Tags Health Care Benzinga Biotech
From Benzinga
Novartis' Fabhalta Delivers Hemoglobin Gains, Reduces Fatigue In Patients With Rare Blood Disorder
Tickers AZN NEWS NVS
Tags AZN Market News Benzinga
From Benzinga
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
Tickers CI CVS FTXH IHE
Tags FTXH pharmacy benefit managers Markets
From Benzinga
AbbVie Scores FDA Approval For Its Blockbuster Drug Rinvoq To Treat Type Of Arthritis
Tickers ABBV NEWS
Tags Health Care Biotech Benzinga
From Benzinga
Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum
Tickers LLY
Tags Analyst Ratings Weight Loss Market News
From Benzinga
Eli Lilly Rallies Over 14%, Notches Best Day Since June 2000 On Oral Weight-Loss Drug Results: Analysts React
Tickers AMGN LLY NVO
Tags Asad Haider NVO AMGN
From Benzinga
Neurocrine Biosciences' Positive Crenessity Physician Survey Turns This Analyst Bullish
Tickers NBIX
Tags Pharmaceutical pharmaceuticals Upgrades
From Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Tickers ABBV AMGN BMY FTXH
Tags BMY XPH GILD
From Benzinga
Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
Tickers AZN BMY NEWS RHHBY
Tags Biotech M&A George Farmer
From Benzinga
Cartesian Therapeutics Reports Strong 12-Month Data For Lead Cell Therapy In Myasthenia Gravis Patients
Tickers NEWS RNAC
Tags RNAC disease Market News
From Benzinga
Sangamo Therapeutics Stock Surges After The Bell: What's Going On?
Tickers LLY NEWS SGMO
Tags After/Hours Center Movers Pharmaceutical
From Benzinga
Edgewise Therapeutics Sees Meaningful HCM Treatment Gains With EDG-7500 In Phase 2 Study
Tickers EWTX NEWS
Tags Market News disease Biotech
From Benzinga
Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data
Tickers NEWS VRTX
Tags Pharmaceutical News VRTX
From Benzinga
Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors
Tickers NEWS REGN SNSE
Tags SNSE General REGN
From Benzinga
Johnson & Johnson's Golden Cross: Technical Momentum Meets Groundbreaking Lung Cancer Breakthrough
Tickers JNJ
Tags Pro Project General lung cancer
From Benzinga
Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial
Tickers RGNX
Tags Movers RGNX Health Care
From Benzinga
FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva
Tickers JNJ NEWS SNY
Tags News Briefs Pharmaceutical
From Benzinga
West Bengal Chemical Industries Limited bagged 9 Patents in API Manufacturing
Tickers API
Tags Business Manufacturing Kolkata
From PRLog
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Tickers MRK NEWS RHHBY SNY
Tags Trading Ideas why it's moving Pharmaceutical
From Benzinga
FDA Rejects Johnson & Johnson's Injectable Version Of Approved Drug For Lung Cancer
Tickers AZN JNJ NEWS
Tags JNJ Pharmaceutical News
From Benzinga
Arizona Pharmacy Association Appoints Garet Turner as New CEO
Tags Pharmacist Health Pharmacy
From PRLog
Syros Pharmaceuticals Stock Sinks As Pivotal Blood Cancer Trial Flunks, Triggers Loan Default
Tickers BMY NEWS SYRS
Tags Health Care Benzinga Biotech
From Benzinga
Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome
Tickers IND NEWS SPRC
Tags medical cannabis drugs Cannabis
From Benzinga
Stock Of The Day: Here's Why Weight-Loss Drug Maker Eli Lilly Has Reversed
Tickers LLY
Tags Expert Ideas Stock of the Day Stories That Matter
From Benzinga
What's Going On With Eli Lilly and Company Shares Friday
Tickers LLY NEWS
Tags Movers LLY Market News
From Benzinga
Stock Of The Day: Moderna Stock Plunges, Breaking Key Support Levels Following Earnings Report
Tickers MRNA
Tags Short Ideas Expert Ideas Stock of the Day
From Benzinga
Why Evoke Pharma (EVOK) Stock Is Volatile
Tickers EVOK NEWS
Tags Stock Split Benzinga News
From Benzinga
Teva's Migraine Treatment Found Effective For Children As Young As 6
Tickers LLY NEWS TEVA
Tags LLY Migraines Health Care
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.